Journal of Nutrition

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adams, M. R.
Right arrow Articles by Anthony, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adams, M. R.
Right arrow Articles by Anthony, M. S.
© 2004 The American Society for Nutritional Sciences J. Nutr. 134:511-516, March 2004


Biochemical and Molecular Actions of Nutrients

Dietary Soy ß-Conglycinin (7S Globulin) Inhibits Atherosclerosis in Mice1,2

Michael R. Adams3, Deborah L. Golden, Adrian A. Franke*, Susan M. Potter{dagger}, Houston S. Smith{dagger} and Mary S. Anthony

Department of Pathology, Section of Comparative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157 * Cancer Research Center of Hawaii, University of Hawaii at Manoa, Honolulu, HI 96813; and the {dagger} Solae Company, St. Louis, MO 63188

3To whom correspondence should be addressed. E-mail: madams{at}wfubmc.edu.

Although ß-conglycinin (7S globulin), a major soy storage protein, stimulates the expression of LDL receptors and the degradation of LDL by hepatocytes in vitro, the in vivo effects of dietary ß-conglycinin on the cardiovascular system are unknown. We assessed the effects of dietary ß-conglycinin and other soy peptide fractions on the development of atherosclerosis in atherosclerosis-susceptible mice. At 6 wk of age, male and ovariectomized female apolipoprotein (apo) E-null mice and LDL receptor-null, apoB transgenic mice were assigned randomly to treatment groups that differed only in the source of dietary protein: 1) casein/lactalbumin, 2) isoflavone-containing soy protein isolate, 3) ß-conglycinin, 4) glycinin (11S globulin, another major soy storage protein), 5) ß-conglycinin-devoid soy protein, and 6) W008 (a peptide fraction produced by hydrolysis and precipitation of soy protein isolate). After 4 mo, aortic atherosclerosis (cholesteryl ester content) and plasma lipoprotein cholesterol concentrations were quantified using GLC. Relative to mice fed casein/lactalbumin–based diets, the extent of atherosclerosis was reduced in ovariectomized female mice fed all soy protein–containing diets. Relative to mice fed isoflavone-containing soy protein isolate, atherosclerosis was reduced only in mice fed the ß-conglycinin–containing diet. Mean reductions were 39 and 67% (all P <0.05) in male and ovariectomized female apoE null mice and 66% (P < 0.05) in male LDL receptor null mice. These effects were unrelated to variation in isoflavone content of the protein source and only minimally related to plasma lipoprotein cholesterol concentrations. We conclude that a diet rich in ß-conglycinin has atheroprotective effects that greatly exceed those of isoflavone-containing soy protein isolate and do not depend on LDL receptors or influences on plasma lipoproteins.


KEY WORDS: • atherosclerosis • mice • soy protein • 7S globulin • lipoproteins




This article has been cited by other articles:


Home page
J. Nutr.Home page
S. Nagarajan, R. L. Burris, B. W. Stewart, J. E. Wilkerson, and T. M. Badger
Dietary Soy Protein Isolate Ameliorates Atherosclerotic Lesions in Apolipoprotein E-Deficient Mice Potentially by Inhibiting Monocyte Chemoattractant Protein-1 Expression
J. Nutr., February 1, 2008; 138(2): 332 - 337.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
C. D. Gardner, M. Messina, A. Kiazand, J. L. Morris, and A. A. Franke
Effect of Two Types of Soy Milk and Dairy Milk on Plasma Lipids in Hypercholesterolemic Adults: A Randomized Trial
J. Am. Coll. Nutr., December 1, 2007; 26(6): 669 - 677.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. W. Erdman Jr., D. Balentine, L. Arab, G. Beecher, J. T. Dwyer, J. Folts, J. Harnly, P. Hollman, C. L. Keen, G. Mazza, et al.
Flavonoids and Heart Health: Proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC
J. Nutr., March 1, 2007; 137(3): 718S - 737S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. A Franke, B. M Halm, L. J Custer, Y. Tatsumura, and S. Hebshi
Isoflavones in breastfed infants after mothers consume soy.
Am. J. Clinical Nutrition, August 1, 2006; 84(2): 406 - 413.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. R. Adams, D. L. Golden, J. K. Williams, A. A. Franke, T. C. Register, and J. R. Kaplan
Soy Protein Containing Isoflavones Reduces the Size of Atherosclerotic Plaques without Affecting Coronary Artery Reactivity in Adult Male Monkeys
J. Nutr., December 1, 2005; 135(12): 2852 - 2856.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
H. M Engelman, D L. Alekel, L. N Hanson, A. G Kanthasamy, and M. B Reddy
Blood lipid and oxidative stress responses to soy protein with isoflavones and phytic acid in postmenopausal women
Am. J. Clinical Nutrition, March 1, 2005; 81(3): 590 - 596.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. C. Register, J. A. Cann, J. R. Kaplan, J. K. Williams, M. R. Adams, T. M. Morgan, M. S. Anthony, R. M. Blair, J. D. Wagner, and T. B. Clarkson
Effects of Soy Isoflavones and Conjugated Equine Estrogens on Inflammatory Markers in Atherosclerotic, Ovariectomized Monkeys
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1734 - 1740.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]